• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Canadian Customs to levy tariffs on Nycomed

Article

The Canadian Customs and Revenue Agency has decided to assess duties on Nycomed Amersham Imaging’s Omnipaque and Visipaque, according to Nycomed Amersham Canada. The move came after Mallinckrodt Medical alleged in June that Oakville, Ontario-based

The Canadian Customs and Revenue Agency has decided to assess duties on Nycomed Amersham Imaging’s Omnipaque and Visipaque, according to Nycomed Amersham Canada. The move came after Mallinckrodt Medical alleged in June that Oakville, Ontario-based Nycomed Amersham Canada was dumping its products on the Canadian market. On Nov. 15, the Canadian commissioner of customs and revenue extended the period of investigation for the charges, and on Dec. 31, made a preliminary determination that dumping had occurred. Nycomed Amersham Canada plans to contest the decision before the Canadian International Trade Tribunal, according to Jean-Pierre Huot, general manager. The tribunal will hold hearings on the case in March, Huot said.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.